Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke.

IVIg treatment tended to reduce the increase in AIF observed following 2–3 h OGD, however this effect did not reach statistical significance (Figure 2 B and 2 C).

also in 111,027 other papers